These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2725061

  • 1. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G, Werter M, De Pauw B, Nerl C, Aulitzky W, von Lüttichau I, Tilg H, Thaler J, Lang A, Abbrederis K.
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [Abstract] [Full Text] [Related]

  • 2. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C, Aulitzky W, Tilg H, von Lüttichau I, Troppmair J, Nachbauer K, Gastl G.
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [Abstract] [Full Text] [Related]

  • 3. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W, Gastl G, Troppmair J, Tilg H, Abbrederis K, Nerl C, Flener R, Rokos H, Huber C.
    Acta Med Austriaca; 1985 Apr; 12(5):115-21. PubMed ID: 3832745
    [Abstract] [Full Text] [Related]

  • 4. A biological approach to optimize interferon treatment in hairy cell leukemia.
    Gastl G, Aulitzky W, Tilg H, Nachbaur K, Troppmair J, Flener R, Huber C.
    Immunobiology; 1986 Sep; 172(3-5):262-8. PubMed ID: 3804368
    [Abstract] [Full Text] [Related]

  • 5. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W, Gastl G, Tilg H, Troppmair J, Leiter E, Geissler D, Flener R, Huber C.
    Wien Med Wochenschr; 1986 Apr 30; 136(7-8):172-81. PubMed ID: 3524022
    [Abstract] [Full Text] [Related]

  • 6. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I, Bettelheim P, Chott A, Herold C, Hinterberger W, Köller U, Kos M, Neumann E, Radaszkiewicz T, Lechner K.
    Wien Klin Wochenschr; 1988 Jan 22; 100(2):47-51. PubMed ID: 3348041
    [Abstract] [Full Text] [Related]

  • 7. Alpha interferon for induction of remission in hairy-cell leukemia.
    Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU.
    N Engl J Med; 1984 Jan 05; 310(1):15-8. PubMed ID: 6689734
    [Abstract] [Full Text] [Related]

  • 8. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM, Dodge R, Mick R, Budman D, Hutchison R, Horning SJ, Schiffer CA.
    Leukemia; 1994 Dec 05; 8(12):2037-40. PubMed ID: 7807991
    [Abstract] [Full Text] [Related]

  • 9. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR, Lepe-Zuniga JL, Gutterman JU.
    Leukemia; 1987 Apr 05; 1(4):317-9. PubMed ID: 3669753
    [Abstract] [Full Text] [Related]

  • 10. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF, Estey EH, Keating MJ, Kurzrock R.
    Leukemia; 1995 May 05; 9(5):929-32. PubMed ID: 7769859
    [Abstract] [Full Text] [Related]

  • 11. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
    Liberati AM, Schippa M, Portuesi MG, Grazia Proietti M, De Angelis V, Ferrajoli A, Cinieri S, Di Clemente F, Palmisano L, Berruto P.
    Haematologica; 1991 May 05; 76(5):375-82. PubMed ID: 1806440
    [Abstract] [Full Text] [Related]

  • 12. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D, Levo Y, Rahmani R, Mory Y, Vaks B, Horowitz O, Doerner T, Shoham J, Wallach D, Revel M.
    Isr J Med Sci; 1985 Dec 05; 21(12):977-81. PubMed ID: 4093298
    [Abstract] [Full Text] [Related]

  • 13. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V, Fehr J, Sauter C, Ottino J.
    Cancer Treat Rev; 1985 Dec 05; 12 Suppl B():33-7. PubMed ID: 3833328
    [Abstract] [Full Text] [Related]

  • 14. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H, Zwingers T, Boedewadt S, Bross K, Dörken B, Gamm H, Ho AD, Parwaresch RM, Schmitz N, Papendick U.
    Onkologie; 1987 Feb 05; 10(1):5-10. PubMed ID: 3295625
    [Abstract] [Full Text] [Related]

  • 15. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ, Bogman MJ, Janssen JT, de Pauw BE, Haanen CA.
    Ned Tijdschr Geneeskd; 1987 Nov 14; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract] [Full Text] [Related]

  • 16. A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
    Pralle H, Zwingers T, Boedewadt S, Bross K, Dörken B, Gamm H, Ho AD, Parwaresch RM, Schmitz N, Papendick U.
    Leukemia; 1987 Apr 14; 1(4):337-40. PubMed ID: 3669759
    [Abstract] [Full Text] [Related]

  • 17. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
    Schiller JH, Storer B, Witt PL, Nelson B, Brown RR, Horisberger M, Grossberg S, Borden EC.
    Cancer Res; 1990 Aug 01; 50(15):4588-94. PubMed ID: 2114942
    [Abstract] [Full Text] [Related]

  • 18. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Ho AD, Thaler J, Mandelli F, Lauria F, Zittoun R, Willemze R, McVie G, Marmont AM, Prümmer O, Stryckmans P.
    J Clin Oncol; 1989 Oct 01; 7(10):1533-8. PubMed ID: 2789273
    [Abstract] [Full Text] [Related]

  • 19. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA, Brady J, Kidd P, Fefer A.
    Cancer Treat Rep; 1985 Oct 01; 69(7-8):791-3. PubMed ID: 4016788
    [Abstract] [Full Text] [Related]

  • 20. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
    Kloke O, May D, Wandl U, Niederle N.
    Onkologie; 1988 Oct 01; 11 Suppl 2():41-5. PubMed ID: 3065687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.